Why chikungunya, other arthritis-causing viruses target joints

May 16, 2018, Washington University School of Medicine
Shown are chikungunya virus particles crystallized into a neat grid. A new study has found the molecular 'handle' the virus uses to enter cells and cause arthritis. Blocking the virus from latching on to the handle could prevent or treat disease. Credit: CDC/CYNTHIA GOLDSMITH

Chikungunya virus is a growing threat to the United States and other regions of the world as the mosquito that carries the virus expands its reach. Telltale symptoms of chikungunya infection are fever and joint pain that last about a week. But in up to half of patients, the virus can cause a debilitating form of arthritis that persists for months or even years.

Scientists have understood little about how chikungunya and related viruses cause arthritis. Now, researchers at Washington University School of Medicine in St. Louis have identified the molecular handle that chikungunya grabs to get inside cells. The findings, published May 16 in the journal Nature, could lead to ways to prevent or treat disease caused by chikungunya and related viruses.

The handle, or receptor, is located on cells that build cartilage, muscle and bone. Joints are filled with such cells, which helps explain patients' painful symptoms. Further, by creating decoy handles, the researchers showed that they could reduce chikungunya infection and signs of arthritis.

"The name chikungunya comes from the Makonde language of Tanzania, and it means 'to walk bent over.' That's how painful the arthritis can be," said senior author Michael S. Diamond, MD, Ph.D., the Herbert S. Gasser Professor of Medicine at the School of Medicine. "We now know how chikungunya gets into cells, and we may have found a way to block the infection. If the cannot get into the cell, it is unable to replicate and cause infection and disease.

There are no specific treatments or vaccines for chikungunya and related viruses, known as arthritogenic alphaviruses. Doctors simply recommend rest, fluids and over-the-counter pain relievers such as acetaminophen or ibuprofen.

With the aid of a warming planet and modern means of transportation, mosquitoes that carry chikungunya and related viruses are spreading. Once limited to Asia and Africa, chikungunya virus has infected more than a million people in the Caribbean and South America in an outbreak that began in 2013 and continues to this day.

Figuring out how the virus gets inside cells is considered a step toward slowing its spread. Diamond, first author and postdoctoral researcher Rong Zhang, Ph.D., and colleagues identified the on cells that latches onto.

The protein is called Mxra8, and it is needed for chikungunya to invade both human and mouse cells, the researchers found. Additional experiments showed that not just chikungunya but its arthritis-causing relatives—Mayaro, Ross River, O'nyongnyong and Barmah Forest viruses—require the protein to get into cells.

Since chikungunya uses Mxra8 protein as a handle to open a door into cells, the researchers tested whether preventing the virus from grabbing that handle could reduce infection. They deluged the virus with decoy handles, reasoning that would grab the decoy and be locked out of cells. Only the few individual viruses that lucked onto a true handle could infect cells, so the overall infection rate—and signs of arthritis—would fall.

And that's just what they found. A day after infection, the level of virus in the mice's ankles and calf muscles was between tenfold and a hundredfold lower in the animals that had been treated with Mxra8 proteins or blocking antibodies than those that received placebo, and the numbers remained lower over the next two days. In addition, three days after treatment, the mice that had received the protein exhibited much less swelling in their ankles than those that received the placebo.

The results suggest that a compound that blocks the virus from attaching to Mxra8 on the surface of could prevent or reduce arthritis.

"Not much is known about what Mxra8 does in the human body, so we need more information before developing a drug that targets Mxra8," said Diamond, who also is a professor of molecular microbiology, and of pathology and immunology. "But we could more immediately develop a drug that targets the virus and prevent it from attaching to this protein."

The researchers are working on mapping the structure of the protein and locating the exact spot to which the virus attaches. Such information could help researchers design a compound to interfere with the virus's ability to hold onto the protein, or to design vaccines to prevent .

Explore further: Studies provide new insights on mosquito-borne chikungunya virus infection

More information: Mxra8 is a receptor for multiple arthritogenic alphaviruses, Nature (2018). nature.com/articles/doi:10.1038/s41586-018-0121-3

Related Stories

Studies provide new insights on mosquito-borne chikungunya virus infection

December 20, 2017
The frequency of chronic joint pain after infection with chikungunya in a large Latin American cohort was 25% at a median of 20-months post-infection. In the Arthritis & Rheumatology study, significant predictors of persistent ...

Drug combination effective against chikungunya arthritis in mice

February 1, 2017
Combining a drug for rheumatoid arthritis with one that targets the chikungunya virus can eliminate the signs of chikungunya arthritis in mice in the disease's earliest stage, according to researchers at Washington University ...

Research points to development of single vaccine for Chikungunya, related viruses​

November 10, 2015
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.

Tropical virus symptoms can mimic rheumatoid arthritis, study says

February 21, 2015
(HealthDay)—The mosquito-borne chikungunya virus causes joint pain and swelling similar to rheumatoid arthritis, which can make diagnosis difficult, a new study says.

Researchers identify mechanism in chikungunya virus that controls infection and severity

January 30, 2017
Researchers led by the Johns Hopkins Bloomberg School of Public Health have identified a mechanism by which the chikungunya virus infects healthy cells and controls how severe the disease it causes will be, a mechanism they ...

Recommended for you

Antibiotic prescribing influenced by team dynamics within hospitals

November 15, 2018
Antibiotic prescribing by doctors is influenced by team dynamics and cultures within hospitals.

Discovery suggests new route to fight infection, disease

November 14, 2018
New research reveals how a single protein interferes with the immune system when exposed to the bacterium that causes Legionnaires' disease, findings that could have broad implications for development of medicines to fight ...

Zika may hijack mother-fetus immunity route

November 14, 2018
To cross the placenta, Zika virus may hijack the route by which acquired immunity is transferred from mother to fetus, new research suggests.

Maternally acquired Zika immunity can increase dengue disease severity in mouse pups

November 14, 2018
To say that the immune system is complex is an understatement: an immune response protective in one context can turn deadly over time, as evidenced by numerous epidemiological studies on dengue infection, spanning multiple ...

New research aims to help improve uptake of hepatitis C testing

November 14, 2018
New research published in Scientific Reports shows persisting fears about HIV infection may impact testing uptake for the hepatitis C Virus (HCV).

Synthetic DNA-delivered antibodies protect against Ebola in preclinical studies

November 13, 2018
Scientists at The Wistar Institute and collaborators have successfully engineered novel DNA-encoded monoclonal antibodies (DMAbs) targeting Zaire Ebolavirus that were effective in preclinical models. Study results, published ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.